دورية أكاديمية

Daratumumab in multiple myeloma.

التفاصيل البيبلوغرافية
العنوان: Daratumumab in multiple myeloma.
المؤلفون: Rajkumar, S. Vincent1 rajkumar.vincent@mayo.edu
المصدر: Lancet. 4/9/2016, Vol. 387 Issue 10027, p1490-1492. 3p. 1 Chart.
مصطلحات موضوعية: MULTIPLE myeloma treatment, ANTIGENS, CD38 antigen, MONOCLONAL antibodies, PROTEASOME inhibitors
مستخلص: The author comments on the use of daratumumab for treatment of multiple myeloma. Topics discussed include the role of daratumumab for targeting CD38 antigen in myeloma cells, the importance of clinical trials for daratumumab monoclonal antibody, and the role of immunomodulatory agent and proteasome inhibitor for myeloma.
قاعدة البيانات: Business Source Index
الوصف
تدمد:01406736
DOI:10.1016/S0140-6736(15)01226-X